149 related articles for article (PubMed ID: 18835041)
1. Iron prochelator BSIH protects retinal pigment epithelial cells against cell death induced by hydrogen peroxide.
Charkoudian LK; Dentchev T; Lukinova N; Wolkow N; Dunaief JL; Franz KJ
J Inorg Biochem; 2008 Dec; 102(12):2130-5. PubMed ID: 18835041
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products.
Jansová H; Bureš J; Macháček M; Hašková P; Jirkovská A; Roh J; Wang Q; Franz KJ; Kovaříková P; Šimůnek T
Toxicology; 2016 Mar; 350-352():15-24. PubMed ID: 27046792
[TBL] [Abstract][Full Text] [Related]
3. Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.
Jansová H; Macháček M; Wang Q; Hašková P; Jirkovská A; Potůčková E; Kielar F; Franz KJ; Simůnek T
Free Radic Biol Med; 2014 Sep; 74():210-21. PubMed ID: 24992833
[TBL] [Abstract][Full Text] [Related]
4. The hydrolytic susceptibility of prochelator BSIH in aqueous solutions.
Wang Q; Franz KJ
Bioorg Med Chem Lett; 2017 Sep; 27(17):4165-4170. PubMed ID: 28734582
[TBL] [Abstract][Full Text] [Related]
5. A pro-chelator triggered by hydrogen peroxide inhibits iron-promoted hydroxyl radical formation.
Charkoudian LK; Pham DM; Franz KJ
J Am Chem Soc; 2006 Sep; 128(38):12424-5. PubMed ID: 16984186
[TBL] [Abstract][Full Text] [Related]
6. LC-UV/MS methods for the analysis of prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH).
Bureš J; Jansová H; Stariat J; Filipský T; Mladěnka P; Šimůnek T; Kučera R; Klimeš J; Wang Q; Franz KJ; Kovaříková P
J Pharm Biomed Anal; 2015 Feb; 105():55-63. PubMed ID: 25527982
[TBL] [Abstract][Full Text] [Related]
7. Modifying aroylhydrazone prochelators for hydrolytic stability and improved cytoprotection against oxidative stress.
Wang Q; Franz KJ
Bioorg Med Chem; 2018 Dec; 26(22):5962-5972. PubMed ID: 30429096
[TBL] [Abstract][Full Text] [Related]
8. Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli.
Lukinova N; Iacovelli J; Dentchev T; Wolkow N; Hunter A; Amado D; Ying GS; Sparrow JR; Dunaief JL
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1440-7. PubMed ID: 19182262
[TBL] [Abstract][Full Text] [Related]
9. SIH--a novel lipophilic iron chelator--protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death.
Simůnek T; Boer C; Bouwman RA; Vlasblom R; Versteilen AM; Sterba M; Gersl V; Hrdina R; Ponka P; de Lange JJ; Paulus WJ; Musters RJ
J Mol Cell Cardiol; 2005 Aug; 39(2):345-54. PubMed ID: 15978614
[TBL] [Abstract][Full Text] [Related]
10. Prochelators triggered by hydrogen peroxide provide hexadentate iron coordination to impede oxidative stress.
Leed MG; Wolkow N; Pham DM; Daniel CL; Dunaief JL; Franz KJ
J Inorg Biochem; 2011 Sep; 105(9):1161-72. PubMed ID: 21708101
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of novel salicylaldehyde isonicotinoyl hydrazone (SIH) analogs: iron chelation, anti-oxidant and cytotoxic properties.
Potůčková E; Hrušková K; Bureš J; Kovaříková P; Špirková IA; Pravdíková K; Kolbabová L; Hergeselová T; Hašková P; Jansová H; Macháček M; Jirkovská A; Richardson V; Lane DJ; Kalinowski DS; Richardson DR; Vávrová K; Šimůnek T
PLoS One; 2014; 9(11):e112059. PubMed ID: 25393531
[TBL] [Abstract][Full Text] [Related]
12. Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity.
Hašková P; Kovaříková P; Koubková L; Vávrová A; Macková E; Simůnek T
Free Radic Biol Med; 2011 Feb; 50(4):537-49. PubMed ID: 21147217
[TBL] [Abstract][Full Text] [Related]
13. 2,6-Dihydroxybenzaldehyde Analogues of the Iron Chelator Salicylaldehyde Isonicotinoyl Hydrazone: Increased Hydrolytic Stability and Cytoprotective Activity against Oxidative Stress.
Jansová H; Kubeš J; Reimerová P; Štěrbová-Kovaříková P; Roh J; Šimůnek T
Chem Res Toxicol; 2018 Nov; 31(11):1151-1163. PubMed ID: 30395451
[TBL] [Abstract][Full Text] [Related]
14. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.
Kurz T; Gustafsson B; Brunk UT
FEBS J; 2006 Jul; 273(13):3106-17. PubMed ID: 16762036
[TBL] [Abstract][Full Text] [Related]
15. Prochelator BHAPI protects cells against paraquat-induced damage by ROS-triggered iron chelation.
Kielar F; Helsel ME; Wang Q; Franz KJ
Metallomics; 2012 Aug; 4(9):899-909. PubMed ID: 22700084
[TBL] [Abstract][Full Text] [Related]
16. Diarylheptanoid 7-(3,4 dihydroxyphenyl)-5-hydroxy-1-phenyl-(1E)-1-heptene from Curcuma comosa Roxb. protects retinal pigment epithelial cells against oxidative stress-induced cell death.
Jitsanong T; Khanobdee K; Piyachaturawat P; Wongprasert K
Toxicol In Vitro; 2011 Feb; 25(1):167-76. PubMed ID: 21044678
[TBL] [Abstract][Full Text] [Related]
17. Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
Lim CK; Kalinowski DS; Richardson DR
Mol Pharmacol; 2008 Jul; 74(1):225-35. PubMed ID: 18424550
[TBL] [Abstract][Full Text] [Related]
18. Modifications of boronic ester pro-chelators triggered by hydrogen peroxide tune reactivity to inhibit metal-promoted oxidative stress.
Charkoudian LK; Pham DM; Kwon AM; Vangeloff AD; Franz KJ
Dalton Trans; 2007 Nov; (43):5031-42. PubMed ID: 17992288
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin sensitive mTOR activation mediates nerve growth factor (NGF) induced cell migration and pro-survival effects against hydrogen peroxide in retinal pigment epithelial cells.
Cao GF; Liu Y; Yang W; Wan J; Yao J; Wan Y; Jiang Q
Biochem Biophys Res Commun; 2011 Oct; 414(3):499-505. PubMed ID: 21968016
[TBL] [Abstract][Full Text] [Related]
20. Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.
Simůnek T; Sterba M; Popelová O; Kaiserová H; Adamcová M; Hroch M; Hasková P; Ponka P; Gersl V
Br J Pharmacol; 2008 Sep; 155(1):138-48. PubMed ID: 18536744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
